In its sector report, “Pharmaceuticals: Securing trust, maintaining profitability" released in December 2014, Sustainalytics assesses the environmental, social and governance (ESG) performance of 132 developed and emerging market pharmaceutical companies, and provides in-depth analysis of three key ESG issues: access to health care, product quality and safety, and business ethics.
In this webinar, Sustainalytics' healthcare expert presents the findings from the sector report and shares insight into why access to healthcare, product quality and safety and business ethics represent the most significant investment risks and opportunities for the pharmaceutical sector. She also discusses the key ESG trends affecting the industry.
Hazel Goedhart, Sector Manager Healthcare and Chemicals
To access the webinar recording, please CLICK HERE